Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Journal of Viral Hepatitis|January 29, 2008
Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV diseaseM R B Hamed, A W Tarr, C P McClure, et al.
Journal for Immunotherapy of Cancer|April 18, 2019
Immunogenicity of immunomodulatory, antibody-based, oncology therapeuticsJasmine Davda, Paul Declerck, Siwen Hu-Lieskovan, et al.
Frontiers in Immunology|January 28, 2026
T cell assays for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity PlatformSophie Tourdot, Anette Christine Karle, Marc Rosenbaum, et al.
Biology|September 28, 2023
Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell EpitopesKatharina Hartman, Guido Steiner, Michel Siegel, et al.
The Journal of General Virology|October 20, 2007
Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33Alexander W Tarr, Ania M Owsianka, Dhanya Jayaraj, et al.
BMC Systems Biology|October 1, 2013
The development of a fully-integrated immune response model (FIRM) simulator of the immune response through integration of multiple subset modelsSirus Palsson, Timothy P Hickling, Erica L Bradshaw-Pierce, et al.
Clinical and Experimental Immunology|February 13, 2018
Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximabB Gorovits, D J Baltrukonis, I Bhattacharya, et al.
Pageof 7